Resistell
Founded 2017 · 14 employees on LinkedIn · 2 known investors
Resistell develops a nanomotion-based diagnostic device for rapid phenotypic antibiotic susceptibility testing (AST), aimed at accelerating detection of antibiotic resistance in hospital settings. The Swiss company's IVD product is intended for clinical microbiology use with bacterial pathogens.
Founders & leadership
Resistell was founded in 2017 by Dr. Danuta Cichocka.
Investors · 2
Frequently asked questions
- What does Resistell do?
- Resistell develops a nanomotion-based diagnostic device for rapid phenotypic antibiotic susceptibility testing (AST), aimed at accelerating detection of antibiotic resistance in hospital settings. The Swiss company's IVD product is intended for clinical microbiology use with bacterial pathogens.
- Who founded Resistell?
- Resistell was founded by Dr. Danuta Cichocka in 2017.
- Who are Resistell's investors?
- Resistell's investors include Alpana Ventures, OCCIDENT.